Sign On | Letter of Thanks to Congress for Introducing Viral Hepatitis Testing Act
Learn more:
Last Updated on July 24, 2023 by HepFree NYC
Tags: Sign On LetterA network building capacity to prevent, manage and treat hepatitis B and C in NYC
Learn more:
Last Updated on July 24, 2023 by HepFree NYC
Tags: Sign On LetterSign on Letter | NYS Medicaid Solvaldi Clinical Criteria Comments (Project Inform) The draft clinical criteria for the use of Sofosbuvir (Sovaldi) under NY State Medicaid is open for public comment. See the details of the comment period and clinical criteria here. Project Inform,...
Thanks to all from the Hepatitis Health Care Access, Insurance & Medications Workgroup who worked on this and took action!!! The vast discrepancy between Prior Authorization Forms utilized by Medicaid Managed Care plans was cited as a significant waste of time & energy ...
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
VOCAL-NY and community leaders will attend the meeting to advocate for unrestricted access to Hepatitis C drug coverage.
At the meeting, Hep Free NYC Ad Board members developed Hep Free NYC goals for 2018.
The NYS Attorney General’s office requests that all patients, their doctors, or their representatives make a call to Health Care Bureau’s toll-free Helpline or fill out a complaint form if they feel they have been wrongly denied coverage for their Hep C treatment medications.
The FY 2017-18 NYC Viral Hep Budget Proposal supports building on the existing success of the City’s viral hepatitis programs, including Check Hep B and C Patient Navigation Program, and Hep C Peer Navigation Program.

We (hepfree.nyc) and selected third parties (7) collect personal information as specified in the privacy policy and use cookies or similar technologies for technical purposes and, with your consent, for functionality, experience, measurement and marketing (personalized ads).
You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel. Denying consent may make related features unavailable.
Use the "Accept all" button to consent. Use the "Reject all" button to continue without accepting.
In this panel you can express preferences for the processing of your personal information. You may review and change your choices at any time.